Cargando…
Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells
Cellular therapies offer a promising therapeutic strategy for the highly malignant brain tumor, glioblastoma (GBM). However, their clinical translation is limited by the lack of effective target identification and stringent testing in pre-clinical models that replicate standard treatment in GBM pati...
Autores principales: | Bhere, Deepak, Choi, Sung Hugh, van de Donk, Pim, Hope, David, Gortzak, Kiki, Kunnummal, Amina, Khalsa, Jasneet, Revai Lechtich, Esther, Reinshagen, Clemens, Leon, Victoria, Nissar, Nabil, Bi, Wenya Linda, Feng, Cheng, Li, Hongbin, Zhang, Yu Shrike, Liang, Steven H., Vasdev, Neil, Essayed, Walid Ibn, Quevedo, Pablo Valdes, Golby, Alexandra, Banouni, Naima, Palagina, Anna, Abdi, Reza, Fury, Brian, Smirnakis, Stelios, Lowe, Alarice, Reeve, Brock, Hiller, Arthur, Chiocca, E. Antonio, Prestwich, Glenn, Wakimoto, Hiroaki, Bauer, Gerhard, Shah, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120173/ https://www.ncbi.nlm.nih.gov/pubmed/35589724 http://dx.doi.org/10.1038/s41467-022-30558-3 |
Ejemplares similares
-
Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy
por: Bhere, Deepak, et al.
Publicado: (2020) -
Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers
por: Kitamura, Yohei, et al.
Publicado: (2021) -
Multimodality resection of Oliveira Type IIIC* cerebellar AVM: A distinct entity
por: Almefty, Rami, et al.
Publicado: (2022) -
Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer
por: Vaughan, Hannah J., et al.
Publicado: (2021) -
Immune Profiling of Syngeneic Murine and Patient GBMs for Effective Translation of Immunotherapies
por: Khalsa, Jasneet Kaur, et al.
Publicado: (2021)